Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,946 | -107,254 | -135,117 | -279,818 | -303,659 |
| Depreciation Amortization | 2,986 | 1,440 | 16,001 | 4,176 | 6,364 |
| Income taxes - deferred | N/A | N/A | -32 | N/A | N/A |
| Accounts receivable | N/A | N/A | 9,333 | -3,706 | 11,032 |
| Other Working Capital | -9,219 | -2,665 | -10,260 | 19,834 | 50,352 |
| Other Operating Activity | 2,549 | 4,403 | -4,291 | 43,299 | 20,203 |
| Operating Cash Flow | $-88,629 | $-104,077 | $-124,366 | $-216,215 | $-215,709 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,325 | 104,500 | 81,458 | -248,529 | -348,953 |
| PPE Investments | -286 | -429 | 5,898 | -969 | -1,231 |
| Purchase Of Investment | N/A | N/A | N/A | -2,000 | N/A |
| Sale Of Investment | N/A | N/A | N/A | 361,084 | 174,840 |
| Investing Cash Flow | $14,039 | $104,071 | $87,356 | $109,586 | $-175,345 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -16,415 | N/A | N/A | N/A |
| Common Stock Issued | 53,161 | 68,311 | 5,462 | 83,238 | 216,110 |
| Other Financing Activity | -111 | -421 | -467 | -1,398 | -4,611 |
| Financing Cash Flow | $53,050 | $51,476 | $4,995 | $81,841 | $211,499 |
| Exchange Rate Effect | N/A | 32 | -4 | -26 | -30 |
| Beginning Cash Position | 65,813 | 14,311 | 46,329 | 71,144 | 250,728 |
| End Cash Position | 44,273 | 65,813 | 14,311 | 46,329 | 71,144 |
| Net Cash Flow | $-21,540 | $51,502 | $-32,019 | $-24,814 | $-179,584 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,629 | -104,077 | -124,366 | -216,215 | -215,709 |
| Capital Expenditure | -286 | -488 | -321 | -969 | -1,231 |
| Free Cash Flow | -88,915 | -104,564 | -124,687 | -217,185 | -216,940 |